These NCCN Clinical Practice Guidelines in Oncology provide recommendations for the management of rectal cancer, beginning with the clinical presentation of the patient to the primary care physician or gastroenterologist through diagnosis, pathologic staging, neoadjuvant treatment, surgical management, adjuvant treatment, surveillance, management of recurrent and metastatic disease, and survivorship. This discussion focuses on localized disease. The NCCN Rectal Cancer Panel believes that a multidisciplinary approach, including representation from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology, is necessary for treating patients with rectal cancer.

  • 1

    SiegelRNaishadhamDJemalA. Cancer statistics, 2012. CA Cancer J Clin2012;62:1029.

  • 2

    ChengLEngCNiemanLZ. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. Am J Clin Oncol2011;34:573580.

    • Search Google Scholar
    • Export Citation
  • 3

    SiegelRWardEBrawleyOJemalA. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin2011;61:212236.

    • Search Google Scholar
    • Export Citation
  • 4

    HemminkiKChenB. Familial risk for colorectal cancers are mainly due to heritable causes. Cancer Epidemiol Biomarkers Prev2004;13:12531256.

    • Search Google Scholar
    • Export Citation
  • 5

    HemminkiKEngC. Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans. J Med Genet2004;41:801807.

    • Search Google Scholar
    • Export Citation
  • 6

    AhsanHNeugutAIGarbowskiGC. Family history of colorectal adenomatous polyps and increased risk for colorectal cancer. Ann Intern Med1998;128:900905.

    • Search Google Scholar
    • Export Citation
  • 7

    BonelliLMartinesHConioM. Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case-control study. Int J Cancer1988;41:513517.

    • Search Google Scholar
    • Export Citation
  • 8

    HampelHFrankelWLMartinE. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol2008;26:57835788.

    • Search Google Scholar
    • Export Citation
  • 9

    LynchHTde la ChapelleA. Hereditary colorectal cancer. N Engl J Med2003;348:919932.

  • 10

    GaliatsatosPFoulkesWD. Familial adenomatous polyposis. Am J Gastroenterol2006;101:385398.

  • 11

    AaltonenLASalovaaraRKristoP. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med1998;338:14811487.

    • Search Google Scholar
    • Export Citation
  • 12

    HampelHFrankelWLMartinE. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med2005;352:18511860.

    • Search Google Scholar
    • Export Citation
  • 13

    HendriksYMde JongAEMorreauH. Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians. CA Cancer J Clin2006;56:213225.

    • Search Google Scholar
    • Export Citation
  • 14

    WrightDMArnoldJLParryB. Immunohistochemistry to detect hereditary nonpolyposis colorectal cancer in young patients: the 7-year Auckland experience. Dis Colon Rectum2011;54:552558.

    • Search Google Scholar
    • Export Citation
  • 15

    Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med2009;11:3541.

    • Search Google Scholar
    • Export Citation
  • 16

    EdgeSBByrdDComptonC eds. AJCC Cancer Staging Manual7th Edition. New York: Springer; 2010.

  • 17

    JessupJMGundersonLLGreeneFL. 2010 staging system for colon and rectal carcinoma. Ann Surg Oncol2011;18:15131517.

  • 18

    AltekruseSFKosaryCLKrapchoM. SEER Cancer Statistics Review 1975–2007. National Cancer Institute. Bethesda, MD. Available at: http://seer.cancer.gov/csr/1975-2007/. Accessed November 5 2012.

    • Search Google Scholar
    • Export Citation
  • 19

    GundersonLLJessupJMSargentDJ. Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes. J Clin Oncol2010;28:256263.

    • Search Google Scholar
    • Export Citation
  • 20

    LoDSPollettASiuLL. Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer. Cancer2008;112:5054.

    • Search Google Scholar
    • Export Citation
  • 21

    NagtegaalIDQuirkeP. Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology2007;51:141149.

  • 22

    PuppaGMaisonneuvePSonzogniA. Pathological assessment of pericolonic tumor deposits in advanced colonic carcinoma: relevance to prognosis and tumor staging. Mod Pathol2007;20:843855.

    • Search Google Scholar
    • Export Citation
  • 23

    UenoHMochizukiH. Clinical significance of extrabowel skipped cancer infiltration in rectal cancer. Surg Today1997;27:617622.

  • 24

    UenoHMochizukiHHashiguchiY. Extramural cancer deposits without nodal structure in colorectal cancer: optimal categorization for prognostic staging. Am J Clin Pathol2007;127:287294.

    • Search Google Scholar
    • Export Citation
  • 25

    WashingtonMKBerlinJBrantonP. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Arch Pathol Lab Med2009;133:15391551.

    • Search Google Scholar
    • Export Citation
  • 26

    ComptonCCFieldingLPBurgartLJ. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med2000;124:979994.

    • Search Google Scholar
    • Export Citation
  • 27

    ComptonCCGreeneFL. The staging of colorectal cancer: 2004 and beyond. CA Cancer J Clin2004;54:295308.

  • 28

    NagtegaalIDMarijnenCAKranenbargEK. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol2002;26:350357.

    • Search Google Scholar
    • Export Citation
  • 29

    NagtegaalIDQuirkeP. What is the role for the circumferential margin in the modern treatment of rectal cancer?J Clin Oncol2008;26:303312.

    • Search Google Scholar
    • Export Citation
  • 30

    WibeARendedalPRSvenssonE. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg2002;89:327334.

    • Search Google Scholar
    • Export Citation
  • 31

    GavioliMLuppiGLosiL. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Dis Colon Rectum2005;48:18511857.

    • Search Google Scholar
    • Export Citation
  • 32

    RodelCMartusPPapadoupolosT. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol2005;23:86888696.

    • Search Google Scholar
    • Export Citation
  • 33

    NissanAStojadinovicAShiaJ. Predictors of recurrence in patients with T2 and early T3, N0 adenocarcinoma of the rectum treated by surgery alone. J Clin Oncol2006;24:40784084.

    • Search Google Scholar
    • Export Citation
  • 34

    FujitaSShimodaTYoshimuraK. Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection. J Surg Oncol2003;84:127131.

    • Search Google Scholar
    • Export Citation
  • 35

    LiebigCAyalaGWilksJ. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol2009;27:51315137.

  • 36

    QuahHMChouJFGonenM. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Dis Colon Rectum2008;51:503507.

    • Search Google Scholar
    • Export Citation
  • 37

    ComptonCC. Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med2006;130:318324.

    • Search Google Scholar
    • Export Citation
  • 38

    LaiLLFullerCDKachnicLAThomasCRJr. Can pelvic radiotherapy be omitted in select patients with rectal cancer?Semin Oncol2006;33:S7074.

    • Search Google Scholar
    • Export Citation
  • 39

    Glynne-JonesRMawdsleySNovellJR. The clinical significance of the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language. Colorectal Dis2006;8:800807.

    • Search Google Scholar
    • Export Citation
  • 40

    AdamIJMohamdeeMOMartinIG. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet1994;344:707711.

    • Search Google Scholar
    • Export Citation
  • 41

    MawdsleySGlynne-JonesRGraingerJ. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?Int J Radiat Oncol Biol Phys2005;63:745752.

    • Search Google Scholar
    • Export Citation
  • 42

    SarliLBaderGIuscoD. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer2005;41:272279.

  • 43

    WongSLJiHHollenbeckBK. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA2007;298:21492154.

  • 44

    PocardMPanisYMalassagneB. Assessing the effectiveness of mesorectal excision in rectal cancer: prognostic value of the number of lymph nodes found in resected specimens. Dis Colon Rectum1998;41:839845.

    • Search Google Scholar
    • Export Citation
  • 45

    TepperJEO’ConnellMJNiedzwieckiD. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol2001;19:157163.

    • Search Google Scholar
    • Export Citation
  • 46

    BaxterNNMorrisAMRothenbergerDATepperJE. Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys2005;61:426431.

    • Search Google Scholar
    • Export Citation
  • 47

    WichmannMWMullerCMeyerG. Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg2002;137:206210.

    • Search Google Scholar
    • Export Citation
  • 48

    TurnerRRNoraDTTrochaSDBilchikAJ. Colorectal carcinoma nodal staging. Frequency and nature of cytokeratin-positive cells in sentinel and nonsentinel lymph nodes. Arch Pathol Lab Med2003;127:673679.

    • Search Google Scholar
    • Export Citation
  • 49

    WoodTFNoraDTMortonDL. One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: detection of missed micrometastases. J Gastrointest Surg2002;6:322329; discussion 229–330.

    • Search Google Scholar
    • Export Citation
  • 50

    YasudaKAdachiYShiraishiN. Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer. Ann Surg Oncol2001;8:300304.

    • Search Google Scholar
    • Export Citation
  • 51

    BraatAEOosterhuisJWMollFC. Sentinel node detection after preoperative short-course radiotherapy in rectal carcinoma is not reliable. Br J Surg2005;92:15331538.

    • Search Google Scholar
    • Export Citation
  • 52

    WieseDSiropSYestrepskyB. Ultrastaging of sentinel lymph nodes (SLNs) vs. non-SLNs in colorectal cancer—do we need both?Am J Surg2010;199:354358; discussion 358.

    • Search Google Scholar
    • Export Citation
  • 53

    NouraSYamamotoHMiyakeY. Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer. Clin Cancer Res2002;8:759767.

    • Search Google Scholar
    • Export Citation
  • 54

    MescoliCAlbertoniLPucciarelliS. Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. J Clin Oncol2012;30:965971.

    • Search Google Scholar
    • Export Citation
  • 55

    RahbariNNBorkUMotschallE. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol2012;30:6070.

    • Search Google Scholar
    • Export Citation
  • 56

    ChungMLeeJTerasawaT. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med2011;155:827838.

    • Search Google Scholar
    • Export Citation
  • 57

    GorhamEDGarlandCFGarlandFC. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med2007;32:210216.

    • Search Google Scholar
    • Export Citation
  • 58

    LappeJMTravers-GustafsonDDaviesKM. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr2007;85:15861591.

    • Search Google Scholar
    • Export Citation
  • 59

    MaYZhangPWangF. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol2011;29:37753782.

    • Search Google Scholar
    • Export Citation
  • 60

    FedirkoVRiboliETjonnelandA. Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations. Cancer Epidemiol Biomarkers Prev2012;21:582593.

    • Search Google Scholar
    • Export Citation
  • 61

    NgKMeyerhardtJAWuK. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol2008;26:29842991.

    • Search Google Scholar
    • Export Citation
  • 62

    NgKSargentDJGoldbergRM. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol2011;29:15991606.

    • Search Google Scholar
    • Export Citation
  • 63

    Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine of the National Academies; 2010. Available at: http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D.aspx. Accessed August 2 2012.

    • Search Google Scholar
    • Export Citation
  • 64

    CooperHSDeppischLMGourleyWK. Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology1995;108:16571665.

    • Search Google Scholar
    • Export Citation
  • 65

    HamiltonSRBosmanFTBoffettaP. Carcinoma of the colon and rectum. In: BosmanFTCarneiroFHrubanRHTheiseND eds. WHO Classification of Tumours of the Digestive System. Lyon: IARC; 2010.

    • Search Google Scholar
    • Export Citation
  • 66

    SeitzUBohnackerSSeewaldS. Is endoscopic polypectomy an adequate therapy for malignant colorectal adenomas? Presentation of 114 patients and review of the literature. Dis Colon Rectum2004;47:17891796.

    • Search Google Scholar
    • Export Citation
  • 67

    UenoHMochizukiHHashiguchiY. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology2004;127:385394.

    • Search Google Scholar
    • Export Citation
  • 68

    VolkEEGoldblumJRPetrasRE. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology1995;109:18011807.

    • Search Google Scholar
    • Export Citation
  • 69

    Garcia-AguilarJHernandez de AndaERothenbergerDA. Endorectal ultrasound in the management of patients with malignant rectal polyps. Dis Colon Rectum2005;48:910916; discussion 916–917.

    • Search Google Scholar
    • Export Citation
  • 70

    WinawerSJZauberAGFletcherRH. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin2006;56:143159; quiz 184–145.

    • Search Google Scholar
    • Export Citation
  • 71

    NelsonHPetrelliNCarlinA. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst2001;93:583596.

  • 72

    KapiteijnEMarijnenCANagtegaalID. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med2001;345:638646.

    • Search Google Scholar
    • Export Citation
  • 73

    SchoellhammerHFGregorianACSarkisyanGGPetrieBA. How important is rigid proctosigmoidoscopy in localizing rectal cancer?Am J Surg2008;196:904908; discussion 908.

    • Search Google Scholar
    • Export Citation
  • 74

    BaxterNNGarcia-AguilarJ. Organ preservation for rectal cancer. J Clin Oncol2007;25:10141020.

  • 75

    RajputABullard DunnK. Surgical management of rectal cancer. Semin Oncol2007;34:241249.

  • 76

    WeiserMRLandmannRGWongWD. Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum2005;48:11691175.

  • 77

    WiigJNLarsenSGGierckskyKE. Operative treatment of locally recurrent rectal cancer. Recent Results Cancer Res2005;165:136147.

  • 78

    BartramCBrownG. Endorectal ultrasound and magnetic resonance imaging in rectal cancer staging. Gastroenterol Clin North Am2002;31:827839.

    • Search Google Scholar
    • Export Citation
  • 79

    BipatSGlasASSlorsFJ. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging—a meta-analysis. Radiology2004;232:773783.

    • Search Google Scholar
    • Export Citation
  • 80

    KlessenCRogallaPTaupitzM. Local staging of rectal cancer: the current role of MRI. Eur Radiol2007;17:379389.

  • 81

    LahayeMJEngelenSMNelemansPJ. Imaging for predicting the risk factors—the circumferential resection margin and nodal disease—of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR2005;26:259268.

    • Search Google Scholar
    • Export Citation
  • 82

    Beets-TanRGBeetsGL. Rectal cancer: review with emphasis on MR imaging. Radiology2004;232:335346.

  • 83

    GuillemJGCohenAM. Current issues in colorectal cancer surgery. Semin Oncol1999;26:505513.

  • 84

    LindsetmoROJohYGDelaneyCP. Surgical treatment for rectal cancer: an international perspective on what the medical gastroenterologist needs to know. World J Gastroenterol2008;14:32813289.

    • Search Google Scholar
    • Export Citation
  • 85

    YouYNBaxterNNStewartANelsonH. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg2007;245:726733.

    • Search Google Scholar
    • Export Citation
  • 86

    NascimbeniRBurgartLJNivatvongsSLarsonDR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum2002;45:200206.

    • Search Google Scholar
    • Export Citation
  • 87

    YamamotoSWatanabeMHasegawaH. The risk of lymph node metastasis in T1 colorectal carcinoma. Hepatogastroenterology2004;51:9981000.

  • 88

    LandmannRGWongWDHoepflJ. Limitations of early rectal cancer nodal staging may explain failure after local excision. Dis Colon Rectum2007;50:15201525.

    • Search Google Scholar
    • Export Citation
  • 89

    NashGMWeiserMRGuillemJG. Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum2009;52:577582.

  • 90

    HealdRJHusbandEMRyallRD. The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?Br J Surg1982;69:613616.

  • 91

    SteupWHMoriyaYvan de VeldeCJH. Patterns of lymphatic spread in rectal cancer. A topographical analysis on lymph node metastases. Eur J Cancer2002;38:911918.

    • Search Google Scholar
    • Export Citation
  • 92

    SchlagPM. Surgical sphincter preservation in rectal cancer. Oncologist1996;1:288292.

  • 93

    MarrRBirbeckKGarvicanJ. The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg2005;242:7482.

    • Search Google Scholar
    • Export Citation
  • 94

    NagtegaalIDvan de VeldeCJvan der WorpE. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol2002;20:17291734.

    • Search Google Scholar
    • Export Citation
  • 95

    ParfittJRDrimanDK. The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment. J Clin Pathol2007;60:849855.

    • Search Google Scholar
    • Export Citation
  • 96

    den DulkMPutterHColletteL. The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer2009;45:11751183.

    • Search Google Scholar
    • Export Citation
  • 97

    PahlmanLBoheMCedermarkB. The Swedish rectal cancer registry. Br J Surg2007;94:12851292.

  • 98

    JayneDGGuillouPJThorpeH. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol2007;25:30613068.

    • Search Google Scholar
    • Export Citation
  • 99

    NgSSMLeungKLLeeJFY. Laparoscopic-assisted versus open abdominoperineal resection for low rectal cancer: a prospective randomized trial. Ann Surg Oncol2008;15:24182425.

    • Search Google Scholar
    • Export Citation
  • 100

    LujanJValeroGBiondoS. Laparoscopic versus open surgery for rectal cancer: results of a prospective multicentre analysis of 4,970 patients. Surg Endoscin press.

    • Search Google Scholar
    • Export Citation
  • 101

    KangSBParkJWJeongSY. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol2010;11:637645.

    • Search Google Scholar
    • Export Citation
  • 102

    JayneDGThorpeHCCopelandJ. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg2010;97:16381645.

    • Search Google Scholar
    • Export Citation
  • 103

    WagmanLD. Laparoscopic and open surgery for colorectal cancer: reaching equipoise?J Clin Oncol2007;25:29962998.

  • 104

    AraujoSEda Silva eSousaAHJrde CamposFG. Conventional approach x laparoscopic abdominoperineal resection for rectal cancer treatment after neoadjuvant chemoradiation: results of a prospective randomized trial. Rev Hosp Clin Fac Med Sao Paulo2003;58:133140.

    • Search Google Scholar
    • Export Citation
  • 105

    KuhryESchwenkWFGaupsetR. Long-term results of laparoscopic colorectal cancer resection. Cochrane Database Syst Rev2008:CD003432.

  • 106

    LeeJKDelaneyCPLipmanJM. Current state of the art in laparoscopic colorectal surgery for cancer: Update on the multi-centric international trials. Ann Surg Innov Res2012;6:5.

    • Search Google Scholar
    • Export Citation
  • 107

    XiongBMaLZhangC. Laparoscopic versus open total mesorectal excision for middle and low rectal cancer: a meta-analysis of results of randomized controlled trials. J Laparoendosc Adv Surg Tech A2012;22:674684.

    • Search Google Scholar
    • Export Citation
  • 108

    PeetersKCvan de VeldeCJLeerJW. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a Dutch colorectal cancer group study. J Clin Oncol2005;23:61996206.

    • Search Google Scholar
    • Export Citation
  • 109

    GundersonLLSargentDJTepperJE. Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol2004;22:17851796.

    • Search Google Scholar
    • Export Citation
  • 110

    TepperJEO’ConnellMNiedzwieckiD. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control—final report of intergroup 0114. J Clin Oncol2002;20:17441750.

    • Search Google Scholar
    • Export Citation
  • 111

    GuillemJGDiaz-GonzalezJAMinskyBD. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol2008;26:368373.

    • Search Google Scholar
    • Export Citation
  • 112

    SauerRBeckerHHohenbergerW. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med2004;351:17311740.

  • 113

    WagmanRMinskyBDCohenAM. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int J Radiat Oncol Biol Phys1998;42:5157.

    • Search Google Scholar
    • Export Citation
  • 114

    SauerRLierschTMerkelS. Preoperative Versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol2012;30:19261933.

    • Search Google Scholar
    • Export Citation
  • 115

    KachnicLA. Should preoperative or postoperative therapy be administered in the management of rectal cancer?Semin Oncol2006;33:S6469.

    • Search Google Scholar
    • Export Citation
  • 116

    BujkoKKepkaLMichalskiWNowackiMP. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol2006;80:412.

    • Search Google Scholar
    • Export Citation
  • 117

    WongRKTandanVDe SilvaSFigueredoA. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev2007:CD002102.

    • Search Google Scholar
    • Export Citation
  • 118

    MadoffRD. Chemoradiotherapy for rectal cancer—when, why, and how?N Engl J Med2004;351:17901792.

  • 119

    O’ConnellMJMartensonJAWieandHS. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med1994;331:502507.

    • Search Google Scholar
    • Export Citation
  • 120

    SmalleySRBenedettiJKWilliamsonSK. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol2006;24:35423547.

    • Search Google Scholar
    • Export Citation
  • 121

    AndreTBoniCNavarroM. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol2009;27:31093116.

    • Search Google Scholar
    • Export Citation
  • 122

    TwelvesCWongANowackiMP. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med2005;352:26962704.

  • 123

    CeelenWPVan NieuwenhoveYFierensK. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Cochrane Database Syst Rev2009:CD006041.

    • Search Google Scholar
    • Export Citation
  • 124

    GerardJPConroyTBonnetainF. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol2006;24:46204625.

    • Search Google Scholar
    • Export Citation
  • 125

    BossetJFCalaisGMineurL. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results—EORTC 22921. J Clin Oncol2005;23:56205627.

    • Search Google Scholar
    • Export Citation
  • 126

    BossetJFColletteLCalaisG. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med2006;355:11141123.

  • 127

    ColletteLBossetJFden DulkM. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol2007;25:43794386.

    • Search Google Scholar
    • Export Citation
  • 128

    HofheinzRDWenzFPostS. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial. Lancet Oncol2012;13:579588.

    • Search Google Scholar
    • Export Citation
  • 129

    RohMSYothersGAO’ConnellMJ. The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum: NSABP R-04 [abstract]. J Clin Oncol2011;29(Suppl):Abstract 3503.

    • Search Google Scholar
    • Export Citation
  • 130

    AscheleCCioniniLLonardiS. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol2011;29:27732780.

    • Search Google Scholar
    • Export Citation
  • 131

    GerardJPAzriaDGourgou-BourgadeS. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol2010;28:16381644.

    • Search Google Scholar
    • Export Citation
  • 132

    GerardJPAzriaDGourgou-BourgadeS. Clinical results at 3 years of the ACCORD 12 randomized trial in rectal cancer [abstract]. J Clin Oncol2012;30(Suppl):Abstract 389.

    • Search Google Scholar
    • Export Citation
  • 133

    RodelCLierschTBeckerH. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol2012.

    • Search Google Scholar
    • Export Citation
  • 134

    Glynne-JonesR. Rectal cancer—the times they are a-changing. Lancet Oncol2012;13:651653.

  • 135

    DewdneyACunninghamDTaberneroJ. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C). J Clin Oncol2012;30:16201627.

    • Search Google Scholar
    • Export Citation
  • 136

    ChioreanEGSanghaniSSchielMA. Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53Cancer Chemother Pharmacol2012;70:2532.

    • Search Google Scholar
    • Export Citation
  • 137

    KimSYHongYSKimDY. Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter phase II study. Int J Radiat Oncol Biol Phys2011;81:677683.

    • Search Google Scholar
    • Export Citation
  • 138

    SpigelDRBendellJCMcCleodM. Phase II study of bevacizumab and chemoradiation in the preoperative or adjuvant treatment of patients with stage II/III rectal cancer. Clin Colorectal Cancer2012;11:4552.

    • Search Google Scholar
    • Export Citation
  • 139

    Fernandez-MartosCAparicioJSaludA. Multicenter randomized phase II study of chemoradiation (CRT) followed by surgery (S) and chemotherapy (CT) versus induction CT followed by CRT and S in high-risk rectal cancer: GCR-3 final efficacy and safety results. J Clin Oncol2009;27(Suppl):Abstract 4103.

    • Search Google Scholar
    • Export Citation
  • 140

    MarechalRVosBPolusM. Short course chemotherapy followed by concomitant chemoradiotherapy and surgery in locally advanced rectal cancer: a randomized multicentric phase II study. Ann Oncol2012;23:15251530.

    • Search Google Scholar
    • Export Citation
  • 141

    NogueMSaludAVicenteP. Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study. Oncologist2011;16:614620.

    • Search Google Scholar
    • Export Citation
  • 142

    GayHABartholdHJO’MearaE. Pelvic normal tissue contouring guidelines for radiation therapy: a radiation therapy oncology group consensus panel atlas. Int J Radiat Oncol Biol Phys2012;83:e353362.

    • Search Google Scholar
    • Export Citation
  • 143

    FrancoisYNemozCJBaulieuxJ. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial. J Clin Oncol1999;17:2396.

    • Search Google Scholar
    • Export Citation
  • 144

    Habr-GamaAPerezROProscurshimI. Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: does delayed surgery have an impact on outcome?Int J Radiat Oncol Biol Phys2008;71:11811188.

    • Search Google Scholar
    • Export Citation
  • 145

    MooreHGGittlemanAEMinskyBD. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum2004;47:279286.

    • Search Google Scholar
    • Export Citation
  • 146

    TulchinskyHShmueliEFigerA. An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer. Ann Surg Oncol2008;15:26612667.

    • Search Google Scholar
    • Export Citation
  • 147

    TranCLUdaniSHoltA. Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer. Am J Surg2006;192:873877.

    • Search Google Scholar
    • Export Citation
  • 148

    Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med1997;336:980987.

    • Search Google Scholar
    • Export Citation
  • 149

    BirgissonHPahlmanLGunnarssonUGlimeliusB. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol2005;23:86978705.

    • Search Google Scholar
    • Export Citation
  • 150

    PeetersKCMJMarijnenCAMNagtegaalID. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg2007;246:693701.

    • Search Google Scholar
    • Export Citation
  • 151

    SiegelRBurockSWerneckeKD. Preoperative short-course radiotherapy versus combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively randomised study of the Berlin Cancer Society. BMC Cancer2009;9:50.

    • Search Google Scholar
    • Export Citation
  • 152

    Sebag-MontefioreDStephensRJSteeleR. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet2009;373:811820.

    • Search Google Scholar
    • Export Citation
  • 153

    StephensRJThompsonLCQuirkeP. Impact of short-course preoperative radiotherapy for rectal cancer on patients’ quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial. J Clin Oncol2010;28:42334239.

    • Search Google Scholar
    • Export Citation
  • 154

    van GijnWMarijnenCANagtegaalID. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol2011;12:575582.

    • Search Google Scholar
    • Export Citation
  • 155

    BujkoKNowackiMPNasierowska-GuttmejerA. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg2006;93:12151223.

    • Search Google Scholar
    • Export Citation
  • 156

    NganSFisherRGoldsteinD. A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: an Intergroup trial (TROG, AGITG, CSSANZ, RACS) [abstract]. J Clin Oncol2010;28;(Suppl):Abstract 3509.

    • Search Google Scholar
    • Export Citation
  • 157

    DasPSkibberJMRodriguez-BigasMA. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol2006;29:219224.

    • Search Google Scholar
    • Export Citation
  • 158

    DasPSkibberJMRodriguez-BigasMA. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer2007;109:17501755.

    • Search Google Scholar
    • Export Citation
  • 159

    FietkauRBartenMKlautkeG. Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum2006;49:12841292.

    • Search Google Scholar
    • Export Citation
  • 160

    ParkIJYouYNAgarwalA. Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J Clin Oncol2012;30:17701776.

    • Search Google Scholar
    • Export Citation
  • 161

    SilberfeinEJKattepoguKMHuCY. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Ann Surg Oncol2010;17:28632869.

    • Search Google Scholar
    • Export Citation
  • 162

    SmithKDTanDDasP. Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation. Ann Surg2010;251:261264.

    • Search Google Scholar
    • Export Citation
  • 163

    PatelUBTaylorFBlomqvistL. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol2011;29:37533760.

    • Search Google Scholar
    • Export Citation
  • 164

    JanjanNACraneCFeigBW. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol2001;24:107112.

    • Search Google Scholar
    • Export Citation
  • 165

    Habr-GamaAPerezRONadalinW. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg2004;240:711717; discussion 717–718.

    • Search Google Scholar
    • Export Citation
  • 166

    Glynne-JonesRWallaceMLivingstoneJIMeyrick-ThomasJ. Complete clinical response after preoperative chemoradiation in rectal cancer: is a “wait and see” policy justified?Dis Colon Rectum2008;51:1019; discussion 19–20.

    • Search Google Scholar
    • Export Citation
  • 167

    MaasMBeets-TanRGLambregtsDM. Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer. J Clin Oncol2011;29:46334640.

    • Search Google Scholar
    • Export Citation
  • 168

    Glynne-JonesRHughesR. Critical appraisal of the ‘wait and see’ approach in rectal cancer for clinical complete responders after chemoradiation. Br J Surg2012;99:897909.

    • Search Google Scholar
    • Export Citation
  • 169

    WolmarkNWieandHSHyamsDM. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst2000;92:388396.

    • Search Google Scholar
    • Export Citation
  • 170

    PetersenSHHarlingHKirkebyLT. Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev2012;3:CD004078.

    • Search Google Scholar
    • Export Citation
  • 171

    BensonABCatalanPMeropolNJ. ECOG E3201: Intergroup randomized phase III study of postoperative irinotecan, 5-fluorouracil (FU), leucovorin (LV) (FOLFIRI) vs oxaliplatin, FU/LV (FOLFOX) vs FU/LV for patients (pts) with stage II/III rectal cancer receiving either pre or postoperative radiation (RT)/FU [abstract]. J Clin Oncol2006;24(Suppl):Abstract 3526.

    • Search Google Scholar
    • Export Citation
  • 172

    FakihM. Treating rectal cancer: key issues reconsidered. Oncology (Williston Park)2008;22:14441446.

  • 173

    MinskyBDGuillemJG. Multidisciplinary management of resectable rectal cancer. New developments and controversies. Oncology (Williston Park)2008;22:14301437.

    • Search Google Scholar
    • Export Citation
  • 174

    AndreTBoniCMounedji-BoudiafL. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med2004;350:23432351.

    • Search Google Scholar
    • Export Citation
  • 175

    BiagiJJRaphaelMJMackillopWJ. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA2011;305:23352342.

    • Search Google Scholar
    • Export Citation
  • 176

    Des GuetzGNicolasPPerretGY. Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur J Cancer2010;46:10491055.

    • Search Google Scholar
    • Export Citation
  • 177

    Comparison of flourouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. QUASAR Collaborative Group. Lancet2000;355:15881596.

    • Search Google Scholar
    • Export Citation
  • 178

    JagerEHeikeMBernhardH. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1. J Clin Oncol1996;14:22742279.

    • Search Google Scholar
    • Export Citation
  • 179

    O’ConnellMJ. A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A Mayo Clinic/North Central Cancer Treatment Group study. Cancer1989;63:10261030.

    • Search Google Scholar
    • Export Citation
  • 180

    Garcia-AguilarJMellgrenASirivongsP. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg2000;231:345351.

    • Search Google Scholar
    • Export Citation
  • 181

    SenguptaSTjandraJJ. Local excision of rectal cancer: what is the evidence?Dis Colon Rectum2001;44:13451361.

  • 182

    WillettCGComptonCCShellitoPCEfirdJT. Selection factors for local excision or abdominoperineal resection of early stage rectal cancer. Cancer1994;73:27162720.

    • Search Google Scholar
    • Export Citation
  • 183

    SchmollHJCartwrightTTaberneroJ. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients. J Clin Oncol2007;25:102109.

    • Search Google Scholar
    • Export Citation
  • 184

    HahnloserDHaddockMGNelsonH. Intraoperative radiotherapy in the multimodality approach to colorectal cancer. Surg Oncol Clin N Am2003;12:9931013ix.

    • Search Google Scholar
    • Export Citation
  • 185

    ValentiniVBalducciMTortoretoF. Intraoperative radiotherapy: current thinking. Eur J Surg Oncol2002;28:180185.

  • 186

    WillettCGCzitoBGTylerDS. Intraoperative radiation therapy. J Clin Oncol2007;25:971977.

  • 187

    PietraNSarliLCostiR. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum1998;41:11271133.

    • Search Google Scholar
    • Export Citation
  • 188

    Rodriguez-MorantaFSaloJArcusaA. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol2006;24:386393.

    • Search Google Scholar
    • Export Citation
  • 189

    SeccoGBFardelliRGianquintoD. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol2002;28:418423.

    • Search Google Scholar
    • Export Citation
  • 190

    DeschCEBensonABSomerfieldMR. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol2005;23:85128519.

    • Search Google Scholar
    • Export Citation
  • 191

    JefferyMHickeyBEHiderPN. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev2007:CD002200.

    • Search Google Scholar
    • Export Citation
  • 192

    RenehanAGEggerMSaundersMPO’DwyerST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ2002;324:813813.

    • Search Google Scholar
    • Export Citation
  • 193

    SargentDJWieandHSHallerDG. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol2005;23:86648670.

    • Search Google Scholar
    • Export Citation
  • 194

    GuyotFFaivreJManfrediS. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol2005;16:756761.

  • 195

    Li DestriGDi CataldoAPuleoS. Colorectal cancer follow-up: useful or useless?Surg Oncol2006;15:112.

  • 196

    PfisterDGBensonABIIISomerfieldMR. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. N Engl J Med2004;350:23752382.

    • Search Google Scholar
    • Export Citation
  • 197

    LockerGYHamiltonSHarrisJ. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol2006;24:53135327.

    • Search Google Scholar
    • Export Citation
  • 198

    MacdonaldJS. Carcinoembryonic antigen screening: pros and cons. Semin Oncol1999;26:556560.

  • 199

    RexDKKahiCJLevinB. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin2006;56:160167.

    • Search Google Scholar
    • Export Citation
  • 200

    GreenRJMetlayJPPropertK. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med2002;136:261269.

    • Search Google Scholar
    • Export Citation
  • 201

    MartinEWMintonJPCareyLC. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma. Ann Surg1985;202:310317.

    • Search Google Scholar
    • Export Citation
  • 202

    YuTKBhosalePRCraneCH. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys2008;71:11751180.

    • Search Google Scholar
    • Export Citation
  • 203

    HoffmanJPRileyLCarpNZLitwinS. Isolated locally recurrent rectal cancer: a review of incidence, presentation, and management. Semin Oncol1993;20:506519.

    • Search Google Scholar
    • Export Citation
  • 204

    LowyAMRichTASkibberJM. Preoperative infusional chemoradiation, selective intraoperative radiation, and resection for locally advanced pelvic recurrence of colorectal adenocarcinoma. Ann Surg1996;223:177185.

    • Search Google Scholar
    • Export Citation
  • 205

    DresenRCGosensMJMartijnH. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol2008;15:19371947.

    • Search Google Scholar
    • Export Citation
  • 206

    KuehneJKleisliTBiernackiP. Use of high-dose-rate brachytherapy in the management of locally recurrent rectal cancer. Dis Colon Rectum2003;46:895899.

    • Search Google Scholar
    • Export Citation
  • 207

    WangJJYuanHSLiJN. CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy. Med Oncol2010;27:421429.

    • Search Google Scholar
    • Export Citation
  • 208

    DasPDelclosMESkibberJM. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys2010;77:6065.

    • Search Google Scholar
    • Export Citation
  • 209

    ValentiniVMorgantiAGGambacortaMA. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study. Int J Radiat Oncol Biol Phys2006;64:11291139.

    • Search Google Scholar
    • Export Citation
  • 210

    SchneiderECMalinJLKahnKL. Surviving colorectal cancer: patient-reported symptoms 4 years after diagnosis. Cancer2007;110:20752082.

  • 211

    DesnooLFaithfullS. A qualitative study of anterior resection syndrome: the experiences of cancer survivors who have undergone resection surgery. Eur J Cancer Care (Engl)2006;15:244251.

    • Search Google Scholar
    • Export Citation
  • 212

    GamiBHarringtonKBlakeP. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther2003;18:987994.

    • Search Google Scholar
    • Export Citation
  • 213

    McGoughCBaldwinCFrostGAndreyevHJ. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. Br J Cancer2004;90:22782287.

    • Search Google Scholar
    • Export Citation
  • 214

    SprangersMATaalBGAaronsonNKte VeldeA. Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Dis Colon Rectum1995;38:361369.

    • Search Google Scholar
    • Export Citation
  • 215

    BaxterNNHabermannEBTepperJE. Risk of pelvic fractures in older women following pelvic irradiation. JAMA2005;294:25872593.

  • 216

    LangeMMMaasCPMarijnenCA. Urinary dysfunction after rectal cancer treatment is mainly caused by surgery. Br J Surg2008;95:10201028.

  • 217

    LangeMMMarijnenCAMaasCP. Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer2009;45:15781588.

  • 218

    DenlingerCSBarsevickAM. The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw2009;7:883893.

  • 219

    FaulLAShibataDTownsendIJacobsenPB. Improving survivorship care for patients with colorectal cancer. Cancer Control2010;17:3543.

  • 220

    DignamJJPoliteBNYothersG. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst2006;98:16471654.

    • Search Google Scholar
    • Export Citation
  • 221

    MeyerhardtJAHeseltineDNiedzwieckiD. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol2006;24:35353541.

    • Search Google Scholar
    • Export Citation
  • 222

    MeyerhardtJANiedzwieckiDHollisD. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA2007;298:754764.

    • Search Google Scholar
    • Export Citation
  • 223

    MeyerhardtJAGiovannucciELOginoS. Physical activity and male colorectal cancer survival. Arch Intern Med2009;169:21022108.

  • 224

    KushiLHByersTDoyleC. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin2006;56:254281; quiz 313–254.

    • Search Google Scholar
    • Export Citation
  • 225

    HewittMGreenfieldSStovallE eds. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: National Academies Press; 2005.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 283 283 36
PDF Downloads 27 27 3
EPUB Downloads 0 0 0